 |
|
Outcomes and Use of Therapeutic Drug Monitoring in Multidrug-Resistant Tuberculosis Patients Treated in Virginia, 2009-2014
Scott K. Heysell, Jane L. Moore, Charles A. Peloquin, David Ashkin, Eric R. Houpt
Tuberc Respir Dis. 2015;78(2):78-84. Published online 2015 Apr 2 DOI: https://doi.org/10.4046/trd.2015.78.2.78
|
|
Citations to this article as recorded by
 Updates in pulmonary drug‐resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM
Dana J. Holger, Ali Althubyani, Taylor Morrisette, Nicholas Rebold, Marylee Tailor
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.2024; 44(3): 268. CrossRef Limited sampling strategies for therapeutic drug monitoring of anti-tuberculosis medications: A systematic review of their feasibility and clinical utility
Rinu Mary Xavier, S.M. Sharumathi, Arun Kanniyappan Parthasarathy, Deepalakshmi Mani, Tharani Mohanasundaram
Tuberculosis.2023; 141: 102367. CrossRef Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease
Connie A Haley, Marcos C Schechter, David Ashkin, Charles A Peloquin, J Peter Cegielski, Barbara B Andrino, Marcos Burgos, Lori A Caloia, Lisa Chen, Angel Colon-Semidey, Malini B DeSilva, Shireesha Dhanireddy, Susan E Dorman, Felicia F Dworkin, Heidi Hamm
Clinical Infectious Diseases.2023; 77(7): 1053. CrossRef Semi-Automated Therapeutic Drug Monitoring as a Pillar toward Personalized Medicine for Tuberculosis Management
Rannissa Puspita Jayanti, Nguyen Phuoc Long, Nguyen Ky Phat, Yong-Soon Cho, Jae-Gook Shin
Pharmaceutics.2022; 14(5): 990. CrossRef Therapeutic drug monitoring in patients with tuberculosis and concurrent medical problems
Anne-Grete Märtson, Gena Burch, Samiksha Ghimire, Jan-Willem C. Alffenaar, Charles A. Peloquin
Expert Opinion on Drug Metabolism & Toxicology.2021; 17(1): 23. CrossRef Linezolid use for the treatment of multidrug-resistant tuberculosis, TB centers of excellence, United States, 2013–2018
Ashley McDowell, Michelle Haas, Barbara Seaworth, John W. Wilson, Amee Patrawalla, Connie Haley, Mike Lauzardo, Miko de Bruyn, Neela D. Goswami
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.2021; 22: 100201. CrossRef Development and validation of a liquid chromatography-tandem mass spectrometry method for quantifying delamanid and its metabolite in small hair samples
Andrew Reckers, Stella Huo, Ali Esmail, Keertan Dheda, Peter Bacchetti, Monica Gandhi, John Metcalfe, Roy Gerona
Journal of Chromatography B.2021; 1169: 122467. CrossRef Promising Ag(I) complexes with N-acylhydrazones from aromatic aldehydes and isoniazid against multidrug resistance in tuberculosis
Paulo Victor P. dos Santos, Camila M. Ribeiro, Fernando R. Pavan, Pedro P. Corbi, Fernando R.G. Bergamini, Marcos A. Carvalho, Kaique A. D'Oliveria, Alexandre Cuin
Journal of Molecular Structure.2021; 1234: 130193. CrossRef Development and validation of a simple LC-MS/MS method for simultaneous determination of moxifloxacin, levofloxacin, prothionamide, pyrazinamide and ethambutol in human plasma
Xubin Zheng, Erwin M. Jongedijk, Yi Hu, Johanna Kuhlin, Rongrong Zheng, Katarina Niward, Jakob Paues, Biao Xu, Lina Davies Forsman, Thomas Schön, Judith Bruchfeld, Jan-Willem C. Alffenaar
Journal of Chromatography B.2020; 1158: 122397. CrossRef Predictors of mortality among multidrug-resistant tuberculosis patients in central Ethiopia: a retrospective follow-up study
Getahun Molla Kassa, Abilo Tadesse, Yalemzewod Assefa Gelaw, Temesgen Tadesse Alemayehu, Adino Tesfahun Tsegaye, Koku Sisay Tamirat, Temesgen Yihunie Akalu
Epidemiology and Infection.2020;[Epub] CrossRef Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis
Wael A. Alghamdi, Abdullah Alsultan, Mohammad H. Al-Shaer, Guohua An, Shahriar Ahmed, Yosra Alkabab, Sayera Banu, Ketevan Barbakadze, Eric Houpt, Maia Kipiani, Lali Mikiashvili, Stephan Schmidt, Scott K. Heysell, Russell R. Kempker, J. Peter Cegielski, Ch
Antimicrobial Agents and Chemotherapy.2019;[Epub] CrossRef Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB
John Metcalfe, Peter Bacchetti, Roy Gerona, Ali Esmail, Keertan Dheda, Monica Gandhi
ERJ Open Research.2019; 5(2): 00046-2019. CrossRef Linezolid-based Regimens for Multidrug-resistant Tuberculosis (TB): A Systematic Review to Establish or Revise the Current Recommended Dose for TB Treatment
Mathieu S Bolhuis, Onno W Akkerman, Marieke G G Sturkenboom, Samiksha Ghimire, Shashikant Srivastava, Tawanda Gumbo, Jan-Willem C Alffenaar
Clinical Infectious Diseases.2018; 67(suppl_3): S327. CrossRef Systematic Review of Salivary Versus Blood Concentrations of Antituberculosis Drugs and Their Potential for Salivary Therapeutic Drug Monitoring
Simone H. J. van den Elsen, Lisette M. Oostenbrink, Scott K. Heysell, Daiki Hira, Daan J. Touw, Onno W. Akkerman, Mathieu S. Bolhuis, Jan-Willem C. Alffenaar
Therapeutic Drug Monitoring.2018; 40(1): 17. CrossRef Linking minimum inhibitory concentrations to whole genome sequence-predicted drug resistance in Mycobacterium tuberculosis strains from Romania
Carolien Ruesen, Anca Lelia Riza, Adriana Florescu, Lidya Chaidir, Cornelia Editoiu, Nicole Aalders, Dragos Nicolosu, Victor Grecu, Mihai Ioana, Reinout van Crevel, Jakko van Ingen
Scientific Reports.2018;[Epub] CrossRef d-Cycloserine Pharmacokinetics/Pharmacodynamics, Susceptibility, and Dosing Implications in Multidrug-resistant Tuberculosis: A Faustian Deal
Devyani Deshpande, Jan-Willem C Alffenaar, Claudio U Köser, Keertan Dheda, Moti L Chapagain, Noviana Simbar, Thomas Schön, Marieke G G Sturkenboom, Helen McIlleron, Pooi S Lee, Thearith Koeuth, Stellah G Mpagama, Sayera Banu, Suporn Foongladda, Oleg Ogark
Clinical Infectious Diseases.2018; 67(suppl_3): S308. CrossRef WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update: Applicability in South Korea
Doosoo Jeon
Tuberculosis and Respiratory Diseases.2017; 80(4): 336. CrossRef Assessment of a 96-Well Plate Assay of Quantitative Drug Susceptibility Testing for Mycobacterium Tuberculosis Complex in China
Hui Xia, Yang Zheng, Bing Zhao, Susan van den Hof, Frank Cobelens, YanLin Zhao, W.C. Yam
PLOS ONE.2017; 12(1): e0169413. CrossRef Simple strategy to assess linezolid exposure in patients with multi-drug-resistant and extensively-drug-resistant tuberculosis
Jasper Kamp, Mathieu S. Bolhuis, Simon Tiberi, Onno W. Akkerman, Rosella Centis, Wiel C. de Lange, Jos G. Kosterink, Tjip S. van der Werf, Giovanni B. Migliori, Jan-Willem C. Alffenaar
International Journal of Antimicrobial Agents.2017; 49(6): 688. CrossRef The Role of Therapeutic Drug Monitoring in Mycobacterial Infections
Charles Peloquin, David Schlossberg
Microbiology Spectrum.2017;[Epub] CrossRef Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis
Marlanka A. Zuur, Mathieu S. Bolhuis, Richard Anthony, Alice den Hertog, Tridia van der Laan, Bob Wilffert, Wiel de Lange, Dick van Soolingen, Jan-Willem C. Alffenaar
Expert Opinion on Drug Metabolism & Toxicology.2016; 12(5): 509. CrossRef Immune formulation-assisted conventional therapy on anti-infective effectiveness of multidrug-resistant Mycobacterium tuberculosis infection mice
Xiu-Li Yuan, Qiang Wen, Ming-De Ni, Li-Kun Wang
Asian Pacific Journal of Tropical Medicine.2016; 9(3): 293. CrossRef Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones
Dario Cattaneo, Jan-Willem Alffenaar, Michael Neely
Expert Opinion on Drug Metabolism & Toxicology.2016; 12(5): 533. CrossRef Urine colorimetry to detect Low rifampin exposure during tuberculosis therapy: a proof-of-concept study
Isaac Zentner, Hans P. Schlecht, Lorna Khensouvann, Neo Tamuhla, Michele Kutzler, Vijay Ivaturi, Jotam G. Pasipanodya, Tawanda Gumbo, Charles A. Peloquin, Gregory P. Bisson, Christopher Vinnard
BMC Infectious Diseases.2016;[Epub] CrossRef Sensititre MycoTB Plate Compared to Bactec MGIT 960 for First- and Second-Line Antituberculosis Drug Susceptibility Testing in Tanzania: a Call To Operationalize MICs
Scott K. Heysell, Suporn Pholwat, Stellah G. Mpagama, Saumu J. Pazia, Happy Kumburu, Norah Ndusilo, Jean Gratz, Eric R. Houpt, Gibson S. Kibiki
Antimicrobial Agents and Chemotherapy.2015; 59(11): 7104. CrossRef
|